Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+131.1%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
12.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.54M | -13.9% |
| 2024 | $12.24M | +210.6% |
| 2023 | $3.94M | +361.5% |
| 2022 | $854147.00 | +518.4% |
| 2021 | $138131.00 | - |